Table 2:
Demonstrates grade 1–2 adverse events for both Arm I and Arm II
|
A. Distribution of Low-Grade (1–2) AEs Per Patient During Chemotherapy
| ||||||||
| Treatment Arm | Sum | Mean | Standard Deviation | Minimum | First Quartile | Median | Third Quartile | Maximum |
|
| ||||||||
| C/P | 394 | 14.07 | 15.31 | 0 | 5.5 | 8.5 | 17 | 68 |
|
| ||||||||
| C/P+T | 481 | 15.03 | 13.68 | 0 | 7 | 10 | 20.5 | 57 |
|
| ||||||||
| Both arms | 875 | 14.58 | 14.35 | 0 | 6 | 9 | 18 | 68 |
|
| ||||||||
|
| ||||||||
|
B. Number of Low-Grade AEs reported
| ||||||||
| System-Organ Class | Grade 1 | Grade 2 | Sum | |||||
|
| ||||||||
| Gastrointestinal disorders | 109 | 37 | 146 | |||||
| Investigations | 74 | 44 | 118 | |||||
| Blood and lymphatic system disorders | 38 | 27 | 65 | |||||
| General disorders and administration site conditions | 65 | 23 | 88 | |||||
| Skin and subcutaneous tissue disorders | 47 | 33 | 80 | |||||
| Metabolism and nutrition disorders | 54 | 16 | 70 | |||||
| Musculoskeletal and connective tissue disorders | 54 | 21 | 75 | |||||
| Nervous system disorders | 59 | 8 | 67 | |||||
| Respiratory, thoracic and mediastinal disorders | 33 | 10 | 43 | |||||
| Vascular disorders | 10 | 8 | 18 | |||||
| Infections and infestations | 12 | 11 | 23 | |||||
| Renal and urinary disorders | 14 | 11 | 25 | |||||
| Psychiatric disorders | 21 | 1 | 22 | |||||
| Reproductive system and breast disorders | 7 | 4 | 11 | |||||
| Eye disorders | 5 | 2 | 7 | |||||
| Ear and labyrinth disorders | 5 | 0 | 5 | |||||
| Injury, poisoning and procedural complications | 4 | 0 | 4 | |||||
| Immune system disorders | 1 | 3 | 4 | |||||
| Cardiac disorders | 4 | 0 | 4 | |||||
|
| ||||||||
| ALL System-Organ Hasses | 616 | 259 | 875 | |||||